Danaher Corporation (DHR)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE
Market Cap: $163.94B
Last updated: Nov 17, 2026 at 11:04 AM ET
Danaher Corporation (DHR) Financials: Revenue, Profit and Cash Flow
Danaher reported revenue of $24.57B for the fiscal year ended Dec 31, 2025, up 2.9% from the year before. That year, net income was $3.61B with a net margin of 14.7%, operating cash flow was $6.42B and free cash flow was $5.26B. The quarter ended Sep 30, 2026 had revenue of $6.55B and net income of $1.24B.
Revenue and Margins
The operating margin was 19.1% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $16.88B, a compound annual rate of 4.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $24.57B | +2.9% | 59.1% | 19.1% | 14.7% |
| Dec 2024 | $23.88B | -0.1% | 59.5% | 20.4% | 16.3% |
| Dec 2023 | $23.89B | -10.3% | 58.7% | 21.8% | 19.9% |
| Dec 2022 | $26.64B | +7.4% | 60.8% | 28.3% | 27.1% |
| Dec 2021 | $24.80B | +11.3% | 61.4% | 25.7% | 25.9% |
| Dec 2020 | $22.28B | +24.4% | 56.0% | 19.0% | 16.4% |
| Dec 2019 | $17.91B | +5.1% | 55.7% | 18.3% | 16.8% |
| Dec 2018 | $17.05B | +9.9% | 55.8% | 17.9% | 15.5% |
| Dec 2017 | $15.52B | -8.1% | 55.2% | 16.6% | 16.1% |
| Dec 2016 | $16.88B | N/A | 55.3% | 16.2% | 15.1% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 7.4% from the year before. In the quarter ended Sep 2026, net income rose 36.6% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B |
| Cost of revenue | $10.04B | $9.67B | $9.86B | $10.46B | $9.56B | $9.81B | $7.93B | $7.54B | $6.95B | $7.55B |
| Gross profit | $14.52B | $14.21B | $14.03B | $16.19B | $15.24B | $12.47B | $9.98B | $9.51B | $8.57B | $9.33B |
| Research and development | $1.60B | $1.58B | $1.50B | $1.53B | $1.50B | $1.35B | $1.13B | $1.06B | $956.40M | $975.10M |
| Operating income | $4.69B | $4.86B | $5.20B | $7.54B | $6.38B | $4.23B | $3.27B | $3.06B | $2.57B | $2.74B |
| Net income | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B |
| EBITDA | $6.92B | $7.18B | $7.20B | $9.44B | $8.95B | $6.96B | $4.47B | $4.27B | $3.79B | $4.10B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.55B | $6.26B | $5.95B | $6.84B | $6.05B | $5.94B | $5.74B | $6.54B | $5.80B | $5.74B | $5.80B | $6.41B |
| Gross profit | $3.84B | $3.61B | $3.59B | $3.97B | $3.52B | $3.52B | $3.51B | $3.89B | $3.40B | $3.43B | $3.49B | $3.78B |
| Operating income | $1.25B | $1.13B | $1.34B | $1.50B | $1.15B | $760.00M | $1.27B | $1.43B | $958.00M | $1.17B | $1.31B | $1.34B |
| Net income | $1.24B | $870.00M | $1.03B | $1.20B | $908.00M | $555.00M | $954.00M | $1.09B | $818.00M | $907.00M | $1.09B | $1.08B |
Balance Sheet
As of Dec 2025, total debt of $18.42B exceeded cash and equivalents by $13.80B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B |
| Current assets | $12.76B | $9.50B | $13.94B | $15.88B | $11.65B | $13.80B | $25.60B | $7.09B | $6.85B | $6.67B |
| Cash and equivalents | $4.62B | $2.08B | $5.86B | $6.00B | $2.59B | $6.04B | $19.91B | $787.80M | $630.30M | $963.70M |
| Total liabilities | $30.92B | $27.99B | $31.00B | $34.26B | $38.01B | $36.38B | $31.80B | $19.61B | $20.28B | $22.22B |
| Short-term debt | $2.00M | $505.00M | $1.70B | $591.00M | $8.00M | $11.00M | $212.00M | $51.80M | $194.70M | $2.59B |
| Long-term debt | $18.42B | $15.50B | $16.71B | $19.09B | $22.17B | $21.19B | $21.52B | $9.69B | $10.33B | $9.67B |
| Shareholder equity | $52.53B | $49.54B | $53.49B | $50.08B | $45.17B | $39.77B | $30.27B | $28.21B | $26.36B | $23.00B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $93.28B | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | $84.49B |
| Total liabilities | $39.65B | $39.77B | $30.59B | $30.93B | $28.82B | $29.28B | $28.26B | $27.99B | $29.31B | $28.65B | $29.95B | $31.00B |
| Cash and equivalents | $5.68B | $4.35B | $5.70B | $4.62B | $1.53B | $2.96B | $1.99B | $2.08B | $2.63B | $2.37B | $7.03B | $5.86B |
| Shareholder equity | $53.62B | $52.58B | $52.95B | $52.53B | $51.07B | $52.33B | $50.85B | $49.54B | $51.30B | $49.90B | $53.44B | $53.49B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 81.9% of operating cash flow. Dividends and share repurchases together came to 75.5% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6.42B | $6.69B | $7.16B | $8.52B | $8.36B | $6.21B | $3.95B | $4.02B | $3.48B | $3.52B |
| Capital expenditures | $1.16B | $1.39B | $1.38B | $1.12B | $1.24B | $791.00M | $636.00M | $584.00M | $570.70M | $589.60M |
| Free cash flow | $5.26B | $5.30B | $5.78B | $7.40B | $7.12B | $5.42B | $3.32B | $3.44B | $2.91B | $2.93B |
| Dividends paid | $878.00M | $768.00M | $1.25B | $818.00M | $742.00M | $615.00M | $527.00M | $433.00M | $442.70M | $399.80M |
| Share repurchases | $3.09B | $5.98B | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | -$1.20B | -$1.98B | -$7.08B | -$2.23B | -$12.99B | -$21.24B | -$1.24B | -$2.95B | -$843.40M | -$5.24B |
| Financing cash flow | -$2.96B | -$8.38B | -$273.00M | -$2.57B | $1.29B | $1.01B | $16.36B | -$797.00M | -$3.10B | $2.04B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.89B | $1.53B | $1.32B | $2.12B | $1.66B | $1.34B | $1.30B | $2.02B | $1.51B | $1.42B | $1.74B | $1.62B |
| Capital expenditures | $255.00M | $269.00M | $237.00M | $371.00M | $292.00M | $248.00M | $245.00M | $516.00M | $298.00M | $287.00M | $291.00M | $434.00M |
| Free cash flow | $1.63B | $1.26B | $1.08B | $1.75B | $1.37B | $1.09B | $1.05B | $1.50B | $1.22B | $1.13B | $1.45B | $1.19B |
Frequently Asked Questions About DHR
What is Danaher's annual revenue?
Danaher reported revenue of $24.57B for the fiscal year ended Dec 31, 2025.
How fast is Danaher's revenue growing?
Revenue was up 2.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -2.7%.
Is Danaher profitable?
Yes. Danaher reported net income of $3.61B for the fiscal year ended Dec 31, 2025, with a net margin of 14.7%.
How much free cash flow does DHR generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $6.42B minus capital expenditures of $1.16B produced free cash flow of $5.26B.
How much debt does Danaher have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $18.42B, short-term debt of $2.00M and cash and equivalents of $4.62B.
DHR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts